News, Resources, and Events Tagged "Innovation"
Alexa Could Diagnose Alzheimer’s and Other Brain Conditions, Should it?: Digital personal assistants could be equipped to diagnose cognitive issues using speech, though the ethics are debatable.
IT’S AN INCREASINGLY common experience: You wander into the kitchen, quietly muttering under your breath, when you hear a disembodied feminine voice say, “I’m…
Apply now! Call for Applications: Research Fellow for the Project on Psychedelics Law and Regulation (POPLAR), Petrie-Flom Center, Harvard Law School
Overview The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is hiring a full-time postdoctoral fellow to support its newly launched Project on Psychedelics Law…
Podcasts now available! 2020 Petrie-Flom Center Annual Conference: Innovation and Protection: The Future of Medical Device Regulation
Notice of Revision In light of developments with COVID-19, we converted our annual conference into a series of podcasts interviewing our contributors.Check out the episodes on This Week in…
Artificial Intelligence and Disability/Dependency: Equity, Access, and Interdependence
Online Viewing Couldn't join us for the live webstream? Join the conversation on Twitter with #AIanddisability, and check out the speakers' slide presentations below! You can also watch the…
Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives: A Health Policy and Bioethics Consortium
Description The traditional model for drug development begins with publicly-funded science based in academic or government laboratories before private investors and for-profit pharmaceutical manufacturers become involved with their substantial expertise…
First Opinion: Do large pharma companies provide drug development innovation?: Our analysis says no
From the article: Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. Reducing their revenues, they contend, will reduce their investment in drug…
Eighth Annual Health Law Year in P/Review
At the Petrie-Flom Center's eighth annual Health Law Year in P/Review, leading experts discussed major developments in health law and policy during 2019 and what to watch out for…
2020 President’s Innovation Challenge, Harvard Innovation Labs
From the website: The President’s Innovation Challenge is a call to action for Harvard students passionate about developing ideas that make a difference. It celebrates what we can…
Research Associate (Health Care), The Institute for Strategy and Competitiveness, Harvard Business School
Duties & Responsibilities The Institute for Strategy and Competitiveness (www.isc.hbs.edu) is a joint Institute of Harvard University and Harvard Business School, dedicated to supporting and extending the…
Grants
From the abstract: Innovation is a primary source of economic growth and is accordingly the target of substantial academic and government attention. Grants are a key tool in the government…
Genome Editing: Rights and Wrongs: A Health Policy and Bioethics Consortium
Gene-editing technologies offer substantial promise in treating disease, but their use raises important ethical and public health questions about how these innovations should be applied and regulated. Different groups have…
Accelerating Alternatives to Animal Experimentation
This panel gave an overview of the current state of developing alternatives to animal use in science and research, before then discussing whether an “accelerator” type business model…
Call to Action: Harvard University President’s Innovation Challenge, Harvard Innovation Labs
From the opportunity: The President’s Innovation Challenge is a call to action, innovation and entrepreneurship. It’s a challenge to the entire Harvard community of students…
Drug Pricing Policies in the United States and Globally: From Development to Delivery
Couldn't join us? Check out the conversation on Twitter: @PetrieFlom #drugpricing and some of our speakers' slide presentations below! Description This one-day conference explored the current pharmaceutical pricing landscape…
Achieving Equitable Access to Vaccines: From Policies to Provisions
Description In order to achieve the objectives of global health organization policies those policies must be translated into actionable provisions and agreements. The Global Healthcare Innovation Alliance Accelerator endeavors to…
New Funding Frontiers: Innovative Funding Models in Translational Research
The working group briefing book is available now for download. Description This one-day working group and conference explored the challenges in pursuing for-profit private funding for early stage translational research.…
The Petrie-Flom Center and Edmond J. Safra Center for Ethics Fellow-in-Residence, Petrie-Flom Center, Harvard Law School, and Edmond J. Safra Center, Harvard University
Each year the Edmond J. Safra Center for Ethics at Harvard University hosts several fellows-in-residence. For 2019-20, they are concentrating their fellowships on the Ethics of Technological…
Petrie-Flom Center and Edmond J. Safra Center for Ethics Fellow-in-Residence: The Ethics of Technological and Biomedical Innovation
Each year the Edmond J. Safra Center for Ethics at Harvard University hosts several fellows-in-residence. For 2019-20, they are concentrating their fellowships on the Ethics of Technological and Biomedical Innovation. …
Administering Health Innovation
From the article: Scholars and policymakers have recently begun to focus on the role federal agencies charged with health-related missions can play in the development of innovative health technologies and…
Drug Approval in a Learning Health System
From the article: The current system of FDA approval seems to make few happy. Some argue FDA approves drugs too slowly; others too quickly. Many agree that FDA—and…
Moratoria and Innovation in the Reproductive Sciences: Of Pretext, Permanence, Transparency, and Timelimits
From the abstract: As progress in the biosciences soldiers forth, new breakthroughs can often be swept up in a common narrative, that is, the narrative of science as a disruptive…
Health Insurance’s Secondary Cost Problem: Market and Mandatory Solutions to Balance Billing and Other Symptoms
From the abstract: This Article identifies a fundamental problem with health insurance and, so, contemporary American health care. While competition pushes health insurers to minimize the primary costs of their…
Circumvention Medical Tourism and Cutting Edge Medicine: The Case of Mitochondrial Replacement Therapy
From the article: “Medical Tourism” is the travel of patients from a home country to a destination country for the primary purpose of receiving health care. “Circumvention…
Sources and Consequences of High Drug Prices in the US: A Health Policy and Bioethics Consortium
Description High drug costs reduce patient adherence and lead to worse outcomes. The process for translating a drug's price, set by the manufacturer, to cost paid by patients and…
Harvard Medical School Annual Bioethics Conference 2018: Defining Death: Organ Transplantation and the 50-Year Legacy of the Harvard Report on Brain Death
The 2018 Annual Bioethics Conference explored the legacy of the 1968 report from the Harvard Medical School committee that proposed the concept of “brain death” as a new criterion for…
Diseases of Despair: The Role of Policy and Law
Description Anne Case and Angus Deaton shocked the world with their 2015 report that noted an increase in all-cause mortality among middle-aged white non-Hispanic men and women in the United States.…
CSPC 2018: Building Bridges Between Science, Policy, and Society, Canadian Science Policy Centre
Overview The Canadian Science Policy Centre announces the call for panel proposals for the 10th Canadian Science Policy Conference (CSPC) to be held in Ottawa, Ontario, …
Petrie-Flom Center launches Project on Precision Medicine, Artificial Intelligence, and the Law
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen…
The Petrie-Flom Center Launches the Innovative Funding Models in Translational Research Project
January 30, 2018 - The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is launching the Innovative Funding Models in Translational Research Project to explore the bioethical,…
Future Directions for Laboratory Animal Law in the United States: Pre-Workshop Webcast and Workshop
Video of the full event will be posted here soon! Want updates sent to your inbox? Sign up for our newsletter! Couldn't join us in person for the January 26…
Apply now! Call for Applications: Research Fellow for Diagnostic Digital Home Health, Petrie-Flom Center, Harvard Law School
Overview The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is hiring a full-time post-doctoral fellow to support its newly launched Diagnostic Digital Home Health…
Research Fellow for Precision Medicine, Petrie-Flom Center, Harvard Law School
Duties & Responsibilities This is a newly created full-time term appointment for a post-doctoral employee needed to support the work of the Petrie-Flom Center on a sponsored research project in…
The Petrie-Flom Center Launches New Project: Precision Medicine, Artificial Intelligence, and the Law (PMAIL)
The Project on Precision Medicine, Artificial Intelligence, and the Law will seek to better understand the frontiers of big data in health care diagnostics, through interdisciplinary analysis of important health…
It’s time to levy penalties for failing to report clinical trial results
From the article: I started my first job as an attorney in the fall of 2007, days after President George W. Bush signed the Food and Drug Administration Amendments Act (FDAAA)…
Postdoc in Economics and Management of Innovation, University of Copenhagen
The Unit for Innovation, Entrepreneurship and Management, Department of Food and Resource Economics (IFRO), Faculty of Science at the University of Copenhagen is offering a 3-year position for a postdoc…
Call for PhD Applications, Collaborative Research Programme in Biomedical Innovation Law (CeBIL), University of Copenhagen
About the programme Supported by a research grant of DKK 35 million from the Novo Nordisk Foundation, the Collaborative Research Programme in Biomedical Innovation Law (CeBIL) will address and…
Sixth Annual Health Law Year in P/Review
Couldn't join us? Check out the conversation on Twitter: @PetrieFlom #healthlawpreview2018 and some of our speakers' slide presentations below! Description The Sixth Annual Health Law Year in P/Review…
Health Law Workshop: Rachel E. Sachs
Presentation Topic: "Delinking Reimbursement" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. About…
Call for Applications: President’s Innovation Challenge, Harvard Innovation Labs
This opportunity is only open to Harvard students. We are pleased to announce the seventh annual President’s Innovation Challenge for entrepreneurship. Hosted by the Harvard Innovation…
HLS in the World: New Technologies, New Dilemmas: Part of the HLS200 Bicentennial Celebration
This event was part of the HLS in the World sessions of HLS │200, a bicentennial summit of academic sessions and programs devoted to legal issues of pressing importance. Panel Description …
Fourth Annual Harvard-UCLA Food Law and Policy Conference: Food Innovation and the Law: Navigating the Next Frontier
The Food Law Lab at Harvard Law School and the Resnick Program for Food Law & Policy at UCLA School of Law hosted the 4th Annual Harvard-UCLA Food Law and…
Mobile Health Innovation and Interagency Coordination
From the paper: An app that can tell when a phone’s owner is having a seizure.1 A device that transforms a phone into a mobile EKG machine.2 An…
The Cost of Medications: Current Realities and the Future of Pharmaceutical Pricing Regulations in the United States
From “Pharma Bro” Martin Shkreli to huge price jumps for the EpiPen to the Hepatitis C treatment that costs $1000 per pill, pharmaceutical pricing is a major issue in…
Health Law Workshop: William M. Sage
Presentation Download the Presentation: "Fracking Health Care: The Need to Safely De-Medicalize America and Recover Trapped Value for Its People" About the Presenter William M. Sage is James R. Dougherty…
Critical Pathways to Improved Care for Serious Illness: Concluding Convening
Download the Report "Toward a Serious Illness Program Design & Implementation Framework" from the roundtables! Couldn't join us for the event? Check out the slide presentation below! At this…
Trying to Keep up with the Health Care Debate on the Hill? Follow These Folks on Twitter
From the article: The GOP effort to repeal and replace Obamacare is picking up steam again as the Senate works on its bill behind closed doors. How to keep track…
(Health) Law and Order
We’ve got a special episode today for all you STEM/legal nerds. Our guest is Rachel Sachs, an Associate Professor at the Washington University in St. Louis School…
Sanofi, Regeneron ask court to shield Dupixent from Amgen patent attack
From the article: [...]Amgen has caught fire for its aggressive stance on its PCSK9 patents, which also protect its own drug in the class, Repatha. Market watchers note that a…
Health Law Workshop: Kathryn Zeiler
Presentation Topic: "Communication-And-Resolution Programs: The Numbers Don’t Add Up" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer…
Regulating Black-Box Medicine
From the abstract: Data drive modern medicine. And our tools to analyze those data are growing ever more powerful. As health data are collected in greater and greater amounts, sophisticated…
Critical Pathways to Improved Care for Serious Illness
This discussion continued at a second roundtable event on June 23, 2017. Learn more on the website! Download the Report "Toward a Serious Illness Program Design & Implementation Framework" from the two…
Research Associate - Healthcare, Harvard Business School
Duties & Responsibilities The Research Associate works directly with Professor Michael Porter as one of his principal, full-time research associates. The role will focus almost exclusively on Professor Porter…
Health Law Workshop: Brendan Maher
About the Presenter Brendan S. Maher is a Professor of Law and the Director of the independently endowed Insurance Law Center at UConn School of Law. A graduate of Stanford…
Looking Forward: The Next Generation of Biosimilars
Couldn't make it to the event? Check out some of the speakers' slides below! Description Many of today’s important medications are biological products made from living organisms,…
Regulating Secrecy
Abstract: Inventors face a stark choice between two intellectual property systems of protecting innovative ideas: patents and trade secrecy. But accounts of this choice underexplore the role of the regulators…
Promoting healthcare innovation on the demand side
Abstract: Innovation policy often focuses on fortifying the incentives of firms that develop and sell new products by offering them lucrative rights to exclude competitors from the market. Regulators also…
Federal Circuit Court Appeal Cites Rachel E. Sachs
No. 17-1480 UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT AMGEN INC., AMGEN MANUFACTURING, LTD., and AMGEN USA, INC., Plaintiffs-Appellees, v. SANOFI, SANOFI-AVENTIS U.S. LLC, AVENTISUB LLC, f…
Regeneron CEO: Amgen’s disruptive Praluent-blocking patent move hurts patients
From the article: Now, Regeneron and Sanofi will ask the Federal Circuit “to quickly review if we can have a stay, and frankly, the merits of the entire case…
Could Amgen’s Patent Victory Be Bad For Medicine?
From the article: Last night, in a nearly unprecedented move, a federal judge ordered a cholesterol medicine that is on the market and used by patients to be withdrawn because…
President-Elect Trump’s Health Policy Agenda: Priorities, Strategies, and Predictions
The Petrie-Flom Center hosted a live web panel to address what health care reform might look like under President-elect Trump's administration. Expert panelists discussed the future of the Affordable…
Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits
From the article: Rachel Sachs, an associate law professor at Washington University in St. Louis and expert in innovation policy, said the government had every right to seek price concessions.…
The Hope and Hype of Precision Medicine: A Health Policy and Bioethics Consortium
Description There has been considerable hype surrounding personalized and precision medicine in the past few years-including President Obama's 2015 announcement of $215 million for the Precision Medicine Initiative. While some policymakers…
Health Care after the Election
Looking for more on this topic now that the election has been decided? Check out our 5th Annual Health Law Year in P/Review on January 23, 2017. At this full-day event,…
PFC Spotlight: Academic Fellow Alumnus Michael Frakes
Michael Frakes was an Academic Fellow from 2009-2011, during which time he researched deterrence and medical malpractice law, culminating in a publication in the University of Chicago Law Review. Today,…
Health Law Workshop: W. Nicholson Price II
Presentation Topic: "Regulating Black-Box Medicine" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. …
President’s Innovation Challenge, Harvard Innovation Lab
General Description: We are pleased to announce the sixth annual President's Innovation Challenge for entrepreneurship. Hosted by the Harvard Innovation Labs, the Challenge amplifies the creativity, diversity,…
Health Law Workshop: Patricia J. Zettler
Presentation Download the Presentation: Pharmaceutical Federalism About the Presenter Patricia J. Zettler is associate professor of law at Georgia State University College of Law. She has expertise in the regulation…
5 reasons why no one has built a better EpiPen
[...] But critics say Mylan has little incentive to improve EpiPens: “If you’re the monopolist, and you’ve got a product that expires every year, and it…
The Coalition to Transform Advanced Care (C-TAC) Launches Service Affiliate C-TAC Innovations,: Which Includes Respecting Choices®
The Coalition to Transform Care (C-TAC) is the Petrie-Flom Center's partner in the Project on Advanced Care and Health Policy, launched in March 2016. La Crosse, WI - C-TAC expands…
Federal Government’s Proposed Expansion of Regulation of Biospecimen Research Should Be Reconsidered: New Commentary from Petrie-Flom Fellowship Alumnus Christopher T. Robertson
Note: The full article is behind a paywall. Abstract: In September, the U.S. Department of Health and Human Services, together with other federal agencies, announced proposed changes to the…
Health Insurance as Innovation Incentive
Excerpt from the article: In Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, Rachel Sachs brings together the often disparate worlds of intellectual property theory and health insurance design, to…
Balancing the Surgeon’s Responsibility to Individuals and Society
From the chapter in The SAGES Manual, Ethics of Surgical Innovation: 18. Balancing the Surgeon’s Responsibility to Individuals and Society Cutting-edge and progressive physicians and surgeons innovate. Indeed, innovation…
Prizing Insurance: Prescription Drug Insurance as Innovation Incentive,: New Article from Academic Fellow Rachel E. Sachs
Abstract: A problem perennially facing scholars of both intellectual property and health law is the need to incentivize appropriately the development of new pharmaceuticals. Although physicians have an arsenal of…
Promoting Healthcare Innovation on the Demand Side
Abstract: Innovation policy often focuses on the incentives of firms that sell new products. But optimal use of healthcare products also requires good information about the likely effects of products…
Book Review: FDA in the Twenty-First Century:The Challenges of Regulating Drugs and New Technologies
From the review: FDA in the 21st Century is an excellent edited volume based on the Petrie–Flom Center's 2013 Annual Conference. The conference sought to gather thought leaders…
Academic Fellow Alumnus W.Nicholson Price II to Join Faculty at University of Michigan School of Law
We are pleased to announce that Petrie-Flom Center Academic Fellow Alumnus W. Nicholson Price II has been appointed an Assistant Professor at the University of Michigan School of Law. Nicholson…
The Future of Health Law and Policy: The Petrie-Flom Center’s 10th Anniversary Conference Celebration
The Petrie-Flom Center celebrated its first decade and kicked off the next by looking at the future of health law and policy! The Center brought together Petrie-Flom and other prominent…
Health Law Workshop: Michael Frakes
Presentation Download the Presentation (two files): "Does Medical Malpractice Law Improve Health Care Quality?" and Appendix About the Presenter In Spring 2016, Michael Frakes was an Associate Professor of Law at…
Negotiating for Health: The Role of Negotiation and Dispute Resolution in Healthcare
Harvard Negotiation Law Review Presents its 21st Annual Symposium Agenda Overview Keynote Address: Dr. Leonard Marcus, Founding Director of the Program for Health Care Negotiation and Conflict Resolution at the…
New Journal of Law & Biosciences featuring Harvard student work
The Journal of Law and the Biosciences, the open-access journal launched in 2014 by the Petrie-Flom Center and Harvard Law School in partnership with Duke University and Stanford University, has published…
Assessing the Viability of FDA’s Biosimilars Pathway
Couldn't attend the event? Check out some of our speakers' slide presentations! Description The 2010 passage of the Biologics Price Competition and Innovation Act was intended to create a pathway…
Academic Fellow Rachel E. Sachs to Join Faculty at Washington University School of Law
We are pleased to announce that Petrie-Flom Center Academic Fellow Rachel E. Sachs has been appointed an Associate Professor at the Washington University in St. Louis School of Law. At…
Fourth Annual Health Law Year in P/Review
Couldn't attend in person? Learn more about the event: Learn more about the presentations - check out select speakers' slides below! Check out the collaborative blog series on the…
A Conversation with Margaret A. Hamburg, FDA Commissioner 2009-2015
Description The Petrie-Flom Center hosted a conversation with former FDA Commissioner (and former New York City Health Commissioner), Dr. Margaret A. Hamburg, led by Peter Barton Hutt, former Chief Counsel…
Academic Fellow Rachel Sachs featured in Politico’s “Prescription Pulse”: Weekly round-up of pharma news includes Sachs on 'march-in' rights
REALITY CHECK ON 'MARCH-IN'-RIGHTS — 50 House Democrats wrote HHS and NIH last week that the government should exercise its march-in rights — handing over the patents on some high-priced…
Why Preventing Cancer Is Not the Priority in Drug Development
From the article: Most people would agree that it would be better to prevent cancer, if we could, than to treat it once it developed. Yet economic incentives encourage researchers…
Innovations in Health Law and Policy: Regulatory Challenges and Strategies for Change Conference: at UNH School of Law
Innovations in Health Law and Policy: Regulatory Challenges and Strategies for Change When: Monday, October 26, 2015 Where: UNH School of Law 2 White Street Concord, New Hampshire Presented by the Health Law…
Heidi Williams wins MacArthur “genius grant”
From the article: MIT economist Heidi Williams, whose scholarly work looks at the effects of patent policies and technology on medical research and health care, has been granted a 2015 MacArthur…
Big Data, Patents, and the Future of Medicine
Abstract: Big data has tremendous potential to improve health care. Unfortunately, intellectual property law isn’t ready to support that leap. In the next wave of data-driven medicine, black-box…
At the Frontier: The Ethics of Innovative Surgery: A Neuroethics Seminar Series Event
All modern surgical techniques were once new, so the ethics of surgical innovation is not a new topic. But as our understanding of the brain advances, so does our ability…
Review of Innovation Law and Policy: Preserving the Future of Personalized Medicine: by Rachel Sachs
From the review: I highly recommend two recently posted articles on declining innovation incentives for diagnostic tests, particularly due to changes in patentable subject matter doctrine. In Innovation Law and…
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?
Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the University of New Hampshire School of Law, and past Visiting Scholar Timo Minnsen, Associate Professor at the University…
Countdown to Cures
From the article: [...] According to Rachel Sachs, an academic fellow at the Petrie-Flom Center at Harvard Law School who has been following the Act with interest, 21st Century Cures has…
Innovation Law and Policy: Preserving the Future of Personalized Medicine
Academic Fellow Rachel E. Sachs has a new article forthcoming in 2016 on law and the future of personalized medicine. From the article: Personalized medicine is the future of health care,…
Health Law Workshop: Rachel E. Sachs
Presentation Topic: "Rethinking the Incentives/Access Dichotomy: Prescription Drug Reimbursement as Innovation Incentive." This paper is not available for download. To request a copy, please contact Jennifer Minnich at jminnich…
FDA’s Impact on Pharmaceutical Innovation: A lecture by Neil Flanzraich
Neil Flanzraich, Chairman and CEO of Cantex Pharmaceuticals, Inc., discussed the balance between speed and safety in FDA’s regulation of pharmaceutical products. Topics included how FDA’s…
Academic Fellow Rachel Sachs Presents at 2015 Works-in-Progress in Intellectual Property Colloquium
Petrie-Flom Academic Fellow Rachel Sachs presented her paper, "Innovation Law and Policy: Preserving the Future of Personalized Medicine," at the 2015 Works-in-Progress in Intellectual Property (WIPIP) Colloquium. Held this year on…
Third Annual Health Law Year in P/Review collaborative blogging with Health Affairs
The Third Annual Health Law Year in P/Review was a big success! Video will be posted on our website shortly, but our presenters will be posting on their respective…
Clinical Trial Recruitment: Problems, Misconceptions, and Possible Solutions,: A Conference
On January 19 - 21, 2015, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard…
Third Annual Health Law Year in P/Review
Couldn't make it in person? Check out the individual sessions in the videos linked above and the collaborative blog series on the Health Affairs Blog (links below)! The Third…